FDA leaders say they've woven feedback into new trial pilot

The FDA’s long-awaited expedited investigational new drug pilot program began accepting applications Tuesday, with top agency officials incorporating public feedback into who should qualify. Karim Mikhail and Michael Davis, the newly named permanent directors of ...